Formulation & Delivery

Optimizing formulation for improved shelf-life, stability, and immunogenicity
New vaccine adjuvants: defining an adjuvant and overcoming regulatory challenges
Ensuring thorough characterization of vaccine/adjuvant formulation
Alternative routes of administration e.g., intranasal, intra/transdermal
Overcoming formulation challenges of combination vaccines
Improved RNA delivery systems – next-gen LNPs and LNP alternatives
Innovative cap analogs for improved stability and reduced immunogenicity of RNA vaccines

}